{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:27:24Z","timestamp":1793878044509,"version":"4.7.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jid.2024.06.1276","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:54:23Z","timestamp":1724979263000},"page":"249-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Pathophysiology of Prurigo Nodularis: Neuroimmune Dysregulation and the Role of Type 2 Inflammation"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3736-1515","authenticated-orcid":false,"given":"Shawn G.","family":"Kwatra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3612-7786","authenticated-orcid":false,"given":"Sonja","family":"St\u00e4nder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6303-1822","authenticated-orcid":false,"given":"Gil","family":"Yosipovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8100-7161","authenticated-orcid":false,"given":"Brian S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0797-5121","authenticated-orcid":false,"given":"Noah A.","family":"Levit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9968-1517","authenticated-orcid":false,"given":"John T.","family":"O\u2019Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2024.06.1276_bib1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2133.1992.tb00452.x","article-title":"Increased sensory neuropeptides in nodular prurigo: a quantitative immunohistochemical analysis","volume":"127","author":"Abad\u00eda Molina","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib3","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.jid.2021.02.749","article-title":"Prurigo nodularis is characterized by systemic and cutaneous T helper 22 immune polarization","volume":"141","author":"Belzberg","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib4","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.4049\/jimmunol.174.6.3695","article-title":"IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes","volume":"174","author":"Boniface","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2024.06.1276_bib5","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jaad.2018.04.047","article-title":"Ethnic differences and comorbidities of 909 prurigo nodularis patients","volume":"79","author":"Boozalis","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5021\/ad.2021.33.4.333","article-title":"Immunohistochemical analysis of prurigo nodularis in 209 patients: clinicopathological analysis between atopic and non-atopic patients and between treatment response groups","volume":"33","author":"Byun","year":"2021","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib7","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaci.2013.10.048","article-title":"A\u00a0sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: involvement of TRPV1 and TRPA1","volume":"133","author":"Cevikbas","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2024.06.1276_bib8","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/bjd\/ljad500","article-title":"Severity, impact on quality of life and mental health burden of pruritus in prurigo nodularis: a cross-sectional study of a diverse patient cohort","volume":"190","author":"Cornman","year":"2024","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib9","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/jamadermatol.2023.2609","article-title":"Modulation of neuroimmune and epithelial dysregulation in patients with moderate to severe prurigo nodularis treated with nemolizumab","volume":"159","author":"Deng","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jaad.2020.07.025","article-title":"Practical approaches for diagnosis and management of prurigo nodularis: United States expert panel consensus","volume":"84","author":"Elmariah","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn4819","article-title":"Miswiring of Merkel cell and pruriceptive C fiber drives the itch-scratch cycle","volume":"14","author":"Feng","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2024.06.1276_bib12","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1365-2133.2011.10498.x","article-title":"Nuclear localization of activated STAT6 and STAT3 in epidermis of prurigo nodularis","volume":"165","author":"Fukushi","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3390\/vaccines9030303","article-title":"Pruritus as a distinctive feature of type 2 inflammation","volume":"9","author":"Garcovich","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jid.2024.06.1276_bib16","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3702","article-title":"Dermal periostin: a new player in itch of prurigo nodularis","volume":"101","author":"Hashimoto","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2024.06.1276_bib15","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/exd.14279","article-title":"Itch intensity in prurigo nodularis is closely related to dermal interleukin-31, oncostatin M, IL-31 receptor alpha and oncostatin M receptor beta","volume":"30","author":"Hashimoto","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13222","article-title":"Dupilumab for prurigo nodularis: case series and review of the literature","volume":"33","author":"Holm","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jid.2024.06.1276_bib18","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jid.2019.07.697","article-title":"Real-world prevalence of prurigo nodularis and burden of associated diseases","volume":"140","author":"Huang","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib19","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.jaad.2020.04.183","article-title":"Prurigo nodularis: epidemiology and clinical features","volume":"83","author":"Huang","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jdin.2023.07.009","article-title":"Risk of incident sleep disorders in patients with prurigo nodularis: a population-level analysis using The Health Improvement Network","volume":"13","author":"Joel","year":"2023","journal-title":"JAAD Int"},{"key":"10.1016\/j.jid.2024.06.1276_bib21","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s00403-001-0285-8","article-title":"Increased nerve growth factor- and tyrosine kinase A-like immunoreactivities in prurigo nodularis skin -- an exploration of the cause of neurohyperplasia","volume":"293","author":"Johansson","year":"2002","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2024.06.1276_bib22","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1172\/JCI124609","article-title":"Neuro-immune crosstalk and allergic inflammation","volume":"129","author":"Kabata","year":"2019","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2024.06.1276_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/039463201402700103","article-title":"Nerve growth factor interactions with mast cells","volume":"27","author":"Kritas","year":"2014","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.jid.2024.06.1276_bib24","article-title":"INDIVIDUAL ARTICLE: patient journey and the burden of systemic comorbidities and sequalae in prurigo nodularis","volume":"22","author":"Kwatra","year":"2023","journal-title":"J\u00a0Drugs Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib25","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa2301333","article-title":"Phase 3 trial of nemolizumab in patients with prurigo nodularis","volume":"389","author":"Kwatra","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2024.06.1276_bib26","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1034\/j.1600-0560.2000.027007359.x","article-title":"CGRP-immunoreactive nerves in prurigo nodularis--an exploration of neurogenic inflammation","volume":"27","author":"Liang","year":"2000","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.jid.2024.06.1276_bib27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1600-0560.1998.tb01718.x","article-title":"Histamine-containing mast cells and their relationship to NGFr-immunoreactive nerves in prurigo nodularis: a reappraisal","volume":"25","author":"Liang","year":"1998","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.jid.2024.06.1276_bib28","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.it.2018.10.001","article-title":"The itch-scratch cycle: a neuroimmune perspective","volume":"39","author":"Mack","year":"2018","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jid.2024.06.1276_bib29","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/genes15020146","article-title":"Dysregulation of the skin-liver axis in prurigo nodularis: an integrated genomic, transcriptomic, and population-based analysis","volume":"15","author":"Marani","year":"2024","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jid.2024.06.1276_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.03.036","article-title":"Periostin activation of integrin receptors on sensory neurons induces allergic itch","volume":"31","author":"Mishra","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.jid.2024.06.1276_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2023.100233","article-title":"Incident comorbidity, resource use, and all-cause mortality associated with prurigo nodularis: a United Kingdom retrospective database analysis","volume":"3","author":"Morgan","year":"2023","journal-title":"JID Innov"},{"key":"10.1016\/j.jid.2024.06.1276_bib32","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/exd.14014","article-title":"Interaction of peripheral nerves and mast cells, eosinophils, and basophils in the development of pruritus","volume":"28","author":"Nakashima","year":"2019","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00403-019-01972-3","article-title":"The IL-4\/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets","volume":"312","author":"Nguyen","year":"2020","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2024.06.1276_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2017.08.006","article-title":"Sensory neurons co-opt classical immune signaling pathways to mediate chronic itch","volume":"171","author":"Oetjen","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jid.2024.06.1276_bib65","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2340\/00015555-2780","article-title":"Role of substance P and its receptor neurokinin 1 in chronic prurigo: a randomized, proof-of-concept, controlled trial with topical aprepitant","volume":"98","author":"Ohanyan","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2024.06.1276_bib35","article-title":"Circulating plasma IL-13 and periostin are dysregulated type 2 inflammatory biomarkers in prurigo nodularis: a cluster analysis","volume":"9","author":"Parthasarathy","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jid.2024.06.1276_bib36","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jaad.2023.01.042","article-title":"The blood proteomic signature of prurigo nodularis reveals distinct inflammatory and neuropathic endotypes: a cluster analysis","volume":"88","author":"Parthasarathy","year":"2023","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2024.01.036","article-title":"Spatial mass cytometry-based single-cell imaging reveals a disrupted epithelial-immune axis in prurigo nodularis [e-pub ahead of print]","author":"Patel","year":"2024","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib38","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jid.2023.12.021","article-title":"Single-cell RNA sequencing reveals dysregulated POSTN+WNT5A+ fibroblast subclusters in prurigo nodularis","volume":"144","author":"Patel","year":"2024","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib39","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/jdv.14570","article-title":"European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo","volume":"32","author":"Pereira","year":"2018","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2024.06.1276_bib40","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jid.2019.05.029","article-title":"Peripheral sensitization and loss of descending inhibition is a hallmark of chronic pruritus","volume":"140","author":"Pogatzki-Zahn","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2133.2011.10306.x","article-title":"Reduced intraepidermal nerve fibre density in lesional and nonlesional prurigo nodularis skin as a potential sign of subclinical cutaneous neuropathy","volume":"165","author":"Schuhknecht","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101826","article-title":"Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor \u03b2 antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study","volume":"57","author":"Sofen","year":"2023","journal-title":"EClinicalmedicine"},{"key":"10.1016\/j.jid.2024.06.1276_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.722170","article-title":"Periostin in allergy and inflammation","volume":"12","author":"Sonnenberg-Riethmacher","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2024.06.1276_bib46","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.jaad.2019.01.052","article-title":"Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial","volume":"80","author":"St\u00e4nder","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib47","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1097\/itx.0000000000000042","article-title":"IFSI-guideline on chronic prurigo including prurigo nodularis","volume":"5","author":"St\u00e4nder","year":"2020","journal-title":"Itch"},{"key":"10.1016\/j.jid.2024.06.1276_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010968","article-title":"Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy","volume":"5","author":"St\u00e4nder","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2024.06.1276_bib49","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/bjd.18025","article-title":"Substance P and neurokinin 1 receptor are new targets for the treatment of chronic pruritus","volume":"181","author":"St\u00e4nder","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib50","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1056\/NEJMoa1908316","article-title":"Trial of nemolizumab in moderate-to-severe prurigo nodularis","volume":"382","author":"St\u00e4nder","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2024.06.1276_bib51","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jid.2021.10.011","article-title":"Cluster analysis of circulating plasma biomarkers in prurigo nodularis reveals a distinct systemic inflammatory signature in African Americans","volume":"142","author":"Sutaria","year":"2022","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib52","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.jid.2022.02.010","article-title":"Cutaneous transcriptomics identifies fibroproliferative and neurovascular gene dysregulation in prurigo nodularis compared with psoriasis and atopic dermatitis","volume":"142","author":"Sutaria","year":"2022","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib53","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jdermsci.2022.02.004","article-title":"Racial differences in dysregulation of the renin-angiotensin-aldosterone system in patients with prurigo nodularis","volume":"105","author":"Sutaria","year":"2022","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2024.06.1276_bib54","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2340\/00015555-3120","article-title":"Aprepitant in anti-histamine-refractory chronic nodular prurigo: a multicentre, randomized, double-blind, placebo-controlled, cross-over, phase-II trial (APREPRU)","volume":"99","author":"Tsianakas","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2024.06.1276_bib55","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.jaci.2021.10.004","article-title":"Transcriptomic characterization of prurigo nodularis and the therapeutic response to nemolizumab","volume":"149","author":"Tsoi","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2024.06.1276_bib56","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/intimm\/dxx040","article-title":"Neuro-immune interactions in allergic diseases: novel targets for therapeutics","volume":"29","author":"Voisin","year":"2017","journal-title":"Int Immunol"},{"key":"10.1016\/j.jid.2024.06.1276_bib57","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jaad.2021.05.036","article-title":"Health-related quality of life and economic burden of prurigo nodularis","volume":"86","author":"Whang","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib58","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jaad.2020.04.182","article-title":"Prurigo nodularis: pathogenesis and management","volume":"83","author":"Williams","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib59","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/bjd.20957","article-title":"Latent class analysis identification of prurigo nodularis comorbidity phenotypes","volume":"186","author":"Wongvibulsin","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib60","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1016\/j.jid.2021.02.756","article-title":"A\u00a0nationwide study of prurigo nodularis: disease burden and healthcare\u00a0utilization in the United States","volume":"141","author":"Wongvibulsin","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2024.06.1276_bib61","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/s41591-023-02320-9","article-title":"Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials","volume":"29","author":"Yosipovitch","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2024.06.1276_bib62","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ejp.767","article-title":"The pathogenesis of Prurigo nodularis--\u2018Super-Itch\u2019 in exploration","volume":"20","author":"Zeidler","year":"2016","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jid.2024.06.1276_bib63","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2340\/00015555-2774","article-title":"Chronic prurigo of nodular type: a review","volume":"98","author":"Zeidler","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2024.06.1276_bib64","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2340\/00015555-3150","article-title":"Aberrant expression of histamine-independent pruritogenic mediators in keratinocytes may be involved in the pathogenesis of prurigo nodularis","volume":"99","author":"Zhong","year":"2019","journal-title":"Acta Derm Venereol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X2401875X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X2401875X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T06:29:21Z","timestamp":1737268161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X2401875X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0022202X2401875X"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2024.06.1276","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathophysiology of Prurigo Nodularis: Neuroimmune Dysregulation and the Role of Type 2 Inflammation","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2024.06.1276","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sanofi and Regeneron Pharmaceuticals Inc. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}